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Background
The surgical treatment of patients affected by BRONJ
(Bisphosphonate-related osteonecrosis of the jaw) repre-
sents one of the most debated issues in the international
literature becouse the data reported to date are preli-
minary results of long-term studies.
In accordance with the guidelines proposed in 2007 by
the American Association of Oral and Maxillofacial Sur-
geons position paper on bisphosphonate-Related Osteo-
necrosis of the Jaws “ and confirmed by the Update
2009 of the same document, surgical treatment should
be reserved only to cases of BRONJ in an advanced
stage (Stage III) or in the presence of a well-defined
bone sequestration. Unfortunately the proposed classifi-
cation, even if very schematic and user-friendly, in our
opinion is still too rigid and does not take into account
the patient as a whole.
Materials and methods
At the University Hospital of Parma, a study group has
been formed since 2005 for the treatment of patients
with BRONJ, involving the various specialties involved
in the management of this disease (dentists, maxillo
facial surgeons, pathologists, medical oncologists)
To date 150 BRONJ patients were enrolled and trea-
ted at the Section of Dentistry and Section of Maxillo-
facial Surgery.
Results
In our patients with BRONJ encouraging results have
been achieved by surgical therapy performed early (stage
I or II, with or without the use of lasers), bringing valu-
able clinical success over 80% of treated sites, compared
with results obtained with medical therapy alone (no
clinical nor symptomatic stable improvement for at least
three months after treatment).
Conclusions
The decision whether to surgically treat the patient not
in an advanced stage, but at the beginnings of necrosis
(e.g., in presence of an asymptomatic mucosal dehis-
cence or of a fistulous intraoral tract) is justified essen-
tially by two elements. The first is that if the bone
involvement is still limited (stage I or II) the interven-
tion will undoubtedly be less burdensome for the patient
with a surgical operation under local anaesthesia and lit-
tle post-operative hospitalization. The second is that the
possibility of a tight closure of mucosal flaps creates an
anatomical barrier to pathogenic microorganisms. In
this way it would limit the risk of progression of infec-
tion with the related complications in terms of symp-
toms and functional impairment..
The School of Parma sustains that, without the possi-
bility to reach healing as histological and radiological
restitution ad integrum, it is necessary to adopt a classi-
fication of the level of clinical results obtained with the
surgical procedure which considers the clinical sympto-
matology and objectivity, called Level Clinical Success.
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